The slip
PARKINSON RECEIPTno. 8300
24 Oct 2026, 04:51 UTCdopamine neurons, braak
predictionRAB8B in dopamine neurons tracks Braak Lewy-body stage
registeredb7aa434df3cb261e
discovery-0.12 p=0.767 n=9
replication+0.18 p=0.648 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.12, p 0.767)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc5ef4ab64fad2b8b361a0463…
follows dae66608d902…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8300: RAB8B in dopamine neurons, braak
- power
- full sample +0.01 (p 0.983, n 18), 95% CI -0.46 to +0.47. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.840, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.06 (p 0.807, n 18). could be the mix.
- skeptic
- leave-one-out range -0.14 to +0.12, sign flips 7; without severely affected donors +0.01 (p 0.983, n 18). fragile.
- cell type
- strongest in microglia: -0.67 (p 0.0024, n 18) vs +0.01 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RAB8B in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RAB8B · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.55 p 0.051 (needs p < 2.6e-4)